Anticoagulants for acute respiratory distress syndrome: can they work?
Idell
S
S
Department of Specialty Care Services, The University of Texas Health Center at Tyler, Tyler, Texas 75708, USA. steven.idell@uthct.edu
D000818:Animals; D004195:Disease Models, Animal; D018450:Disease Progression; D004353:Drug Evaluation, Preclinical; D005337:Fibrin / Q000187:drug effects / Q000502:physiology; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008074:Lipoproteins / Q000494:pharmacology / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000209:etiology / Q000517:prevention & control; D011486:Protein C / Q000494:pharmacology / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000401:mortality; D018805:Sepsis / Q000150:complications; D016896:Treatment Outcome
D008074:Lipoproteins; D011486:Protein C; C051928:lipoprotein-associated coagulation inhibitor; D005337:Fibrin